000168383 001__ 168383
000168383 005__ 20240229133607.0
000168383 0247_ $$2doi$$a10.1158/1055-9965.EPI-20-1726
000168383 0247_ $$2pmid$$apmid:33849969
000168383 0247_ $$2ISSN$$a1055-9965
000168383 0247_ $$2ISSN$$a1538-7755
000168383 0247_ $$2altmetric$$aaltmetric:103884168
000168383 037__ $$aDKFZ-2021-00870
000168383 041__ $$aEnglish
000168383 082__ $$a610
000168383 1001_ $$00000-0001-6517-1300$$aHeath, Alicia K$$b0
000168383 245__ $$aSoft drink and juice consumption and renal cell carcinoma incidence and mortality in the European Prospective Investigation into Cancer and Nutrition.
000168383 260__ $$aPhiladelphia, Pa.$$bAACR$$c2021
000168383 3367_ $$2DRIVER$$aarticle
000168383 3367_ $$2DataCite$$aOutput Types/Journal article
000168383 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1625058669_23645
000168383 3367_ $$2BibTeX$$aARTICLE
000168383 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000168383 3367_ $$00$$2EndNote$$aJournal Article
000168383 500__ $$a2021 Jun;30(6):1270-1274
000168383 520__ $$aRenal cell carcinoma (RCC) accounts for more than 80% of kidney cancers in adults and obesity is a known risk factor. Regular consumption of sweetened beverages has been linked to obesity and several chronic diseases including some types of cancer. It is uncertain whether soft drink and juice consumption is associated with risk of RCC. We investigated the associations of soft drink and juice consumption with RCC incidence and mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC).389,220 EPIC participants with median age 52 years at recruitment (1991-2000) were included. Cox regression yielded adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for RCC incidence and mortality in relation to intakes of juices and total, sugar-sweetened, and artificially-sweetened soft drinks.888 incident RCCs and 356 RCC deaths were identified. In models including adjustment for body mass index and energy intake, there was no higher risk of incident RCC associated with consumption of juices (HR per 100 g/day increment=1.03, 95% CI 0.97-1.09), total soft drinks (HR=1.01, 0.98-1.05), sugar-sweetened soft drinks (HR=0.99, 0.94-1.05), or artificially-sweetened soft drinks (HR=1.02, 0.96-1.08). In these fully-adjusted models, none of the beverages were associated with RCC mortality (HR, 95% CI per 100 g/day increment 1.06, 0.97-1.16; 1.03, 0.98-1.09; 0.97, 0.89-1.07; and 1.06, 0.99-1.14, respectively).Consumption of juices or soft drinks was not associated with RCC incidence or mortality after adjusting for obesity.Soft drink and juice intakes are unlikely to play an independent role in RCC development or mortality.
000168383 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000168383 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000168383 7001_ $$00000-0003-4231-5740$$aClasen, Joanna L$$b1
000168383 7001_ $$00000-0002-6906-4219$$aJayanth, Nick P$$b2
000168383 7001_ $$aJenab, Mazda$$b3
000168383 7001_ $$00000-0003-4385-2097$$aTjonneland, Anne$$b4
000168383 7001_ $$aPetersen, Kristina E N$$b5
000168383 7001_ $$aOvervad, Kim$$b6
000168383 7001_ $$0P:(DE-He78)0644671d309776d45e0fc705d1156cac$$aSrour, Bernard$$b7$$udkfz
000168383 7001_ $$0P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aKatzke, Verena$$b8$$udkfz
000168383 7001_ $$00000-0001-5064-227X$$aBergmann, Manuela M$$b9
000168383 7001_ $$00000-0002-0830-5277$$aSchulze, Matthias B$$b10
000168383 7001_ $$00000-0002-5758-9069$$aMasala, Giovanna$$b11
000168383 7001_ $$00000-0003-0122-8624$$aKrogh, Vittorio$$b12
000168383 7001_ $$00000-0003-2666-414X$$aTumino, Rosario$$b13
000168383 7001_ $$00000-0003-2597-2060$$aCatalano, Alberto$$b14
000168383 7001_ $$aPasanisi, Fabrizio$$b15
000168383 7001_ $$aBrustad, Magritt$$b16
000168383 7001_ $$00000-0002-2539-4603$$aOlsen, Karina Standahl$$b17
000168383 7001_ $$00000-0003-2476-4251$$aSkeie, Guri$$b18
000168383 7001_ $$00000-0001-6224-1764$$aLujan-Barroso, Leila$$b19
000168383 7001_ $$00000-0002-9972-9779$$aRodríguez-Barranco, Miguel$$b20
000168383 7001_ $$aAmiano, Pilar$$b21
000168383 7001_ $$aSantiuste, Carmen$$b22
000168383 7001_ $$aBarricarte Gurrea, Aurelio$$b23
000168383 7001_ $$aAxelson, Håkan$$b24
000168383 7001_ $$00000-0003-1291-4494$$aRamne, Stina$$b25
000168383 7001_ $$00000-0002-4121-3753$$aLjungberg, Borje$$b26
000168383 7001_ $$00000-0001-9229-2589$$aWatts, Eleanor L$$b27
000168383 7001_ $$00000-0003-3838-855X$$aHuybrechts, Inge$$b28
000168383 7001_ $$00000-0003-2237-0128$$aWeiderpass, Elisabete$$b29
000168383 7001_ $$aRiboli, Elio$$b30
000168383 7001_ $$aMuller, David C$$b31
000168383 773__ $$0PERI:(DE-600)2036781-8$$a10.1158/1055-9965.EPI-20-1726$$gp. cebp.1726.2020 -$$n6$$p1270-1274$$tCancer epidemiology, biomarkers & prevention$$v30$$x1538-7755$$y2021
000168383 909CO $$ooai:inrepo02.dkfz.de:168383$$pVDB
000168383 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0644671d309776d45e0fc705d1156cac$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000168383 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000168383 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000168383 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000168383 9141_ $$y2021
000168383 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-02-02
000168383 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-02-02
000168383 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-02-02
000168383 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-02-02
000168383 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-02
000168383 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-02-02
000168383 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-02-02
000168383 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-02-02
000168383 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-02
000168383 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-02-02
000168383 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER EPIDEM BIOMAR : 2019$$d2021-02-02
000168383 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-02-02
000168383 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000168383 980__ $$ajournal
000168383 980__ $$aVDB
000168383 980__ $$aI:(DE-He78)C020-20160331
000168383 980__ $$aUNRESTRICTED